2023 Q3 Form 10-Q Financial Statement

#000144364623000174 Filed on July 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $2.666B $2.654B $2.250B
YoY Change 15.98% 18.0% 13.1%
Cost Of Revenue $1.233B $1.252B $1.075B
YoY Change 16.57% 16.46% 11.66%
Gross Profit $1.434B $1.403B $1.175B
YoY Change 15.47% 19.41% 14.45%
Gross Profit Margin 53.77% 52.84% 52.21%
Selling, General & Admin $300.6M $283.3M $248.0M
YoY Change 8.25% 14.24% 5.51%
% of Gross Profit 20.97% 20.2% 21.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $41.00M $41.85M $40.10M
YoY Change 4.99% 4.35% 44.54%
% of Gross Profit 2.86% 2.98% 3.41%
Operating Expenses $1.166B $1.137B $962.3M
YoY Change 16.44% 18.19% 17.6%
Operating Profit $267.0M $265.1M $207.2M
YoY Change 19.23% 27.97% 46.68%
Interest Expense $44.76M -$35.47M $24.66M
YoY Change 57.91% -243.88% 15.91%
% of Operating Profit 16.76% -13.38% 11.9%
Other Income/Expense, Net $3.556M $1.924M -$2.958M
YoY Change -86.56% -165.04% 454.97%
Pretax Income $225.8M $200.9M $179.6M
YoY Change 1.69% 11.85% 50.34%
Income Tax $55.07M $39.48M $41.49M
% Of Pretax Income 24.39% 19.65% 23.1%
Net Earnings $170.7M $160.1M $138.3M
YoY Change -0.13% 15.81% 50.14%
Net Earnings / Revenue 6.4% 6.03% 6.15%
Basic Earnings Per Share $1.29 $1.22 $1.04
Diluted Earnings Per Share $1.29 $1.22 $1.03
COMMON SHARES
Basic Shares Outstanding 131.0M shares 130.8M shares 132.2M shares
Diluted Shares Outstanding 131.1M shares 131.5M shares 133.0M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $557.3M $209.6M $497.8M
YoY Change -26.33% -57.89% -19.95%
Cash & Equivalents $557.3M $209.6M $497.8M
Short-Term Investments
Other Short-Term Assets $133.4M $98.15M $94.95M
YoY Change -56.37% 3.37% -47.88%
Inventory
Prepaid Expenses
Receivables $2.010B $2.100B $1.828B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.701B $2.408B $2.421B
YoY Change -0.64% -0.55% -2.25%
LONG-TERM ASSETS
Property, Plant & Equipment $178.9M $366.4M $194.9M
YoY Change -6.45% 87.97% -0.5%
Goodwill $2.344B $2.344B $2.022B
YoY Change 16.32% 15.92% 5.02%
Intangibles $637.8M $657.8M $626.9M
YoY Change 5.03% 4.92% 2.81%
Long-Term Investments
YoY Change
Other Assets $298.3M $930.8M $484.0M
YoY Change -37.27% 92.32% -10.27%
Total Long-Term Assets $4.462B $4.359B $3.541B
YoY Change 27.94% 23.08% 0.94%
TOTAL ASSETS
Total Short-Term Assets $2.701B $2.408B $2.421B
Total Long-Term Assets $4.462B $4.359B $3.541B
Total Assets $7.163B $6.766B $5.962B
YoY Change 15.42% 13.48% -0.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $603.2M $572.4M $502.4M
YoY Change 11.22% 13.93% 4.97%
Accrued Expenses $453.2M $1.237B $396.0M
YoY Change 12.61% 212.52% 14.9%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $41.25M $116.3M $68.38M
YoY Change 0.0% 70.01% -12.18%
Total Short-Term Liabilities $1.606B $1.992B $1.516B
YoY Change 7.04% 31.43% 10.58%
LONG-TERM LIABILITIES
Long-Term Debt $3.389B $2.761B $2.715B
YoY Change 21.47% 1.69% -2.0%
Other Long-Term Liabilities $145.8M $995.5M $343.7M
YoY Change -69.93% 189.63% 44.19%
Total Long-Term Liabilities $3.535B $3.757B $3.059B
YoY Change 7.94% 22.8% 1.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.606B $1.992B $1.516B
Total Long-Term Liabilities $3.535B $3.757B $3.059B
Total Liabilities $6.090B $5.749B $4.863B
YoY Change 22.12% 18.22% -1.98%
SHAREHOLDERS EQUITY
Retained Earnings $2.259B $2.150B $2.095B
YoY Change 2.26% 2.64% 16.46%
Common Stock $835.7M $806.9M $681.3M
YoY Change 17.99% 18.44% 17.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.072B $1.017B $1.098B
YoY Change
Total Liabilities & Shareholders Equity $7.163B $6.766B $5.962B
YoY Change 15.42% 13.48% -0.38%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $170.7M $160.1M $138.3M
YoY Change -0.13% 15.81% 50.14%
Depreciation, Depletion And Amortization $41.00M $41.85M $40.10M
YoY Change 4.99% 4.35% 44.54%
Cash From Operating Activities -$47.40M -$71.53M -$45.63M
YoY Change -117.38% 56.75% 328.01%
INVESTING ACTIVITIES
Capital Expenditures $16.90M $10.49M -$13.73M
YoY Change -205.63% -176.37% 52.46%
Acquisitions $406.0K $0.00
YoY Change -100.0%
Other Investing Activities -$5.000M -$4.566M $0.00
YoY Change -111.35% -100.0%
Cash From Investing Activities -$21.90M -$15.05M -$13.73M
YoY Change -178.04% 9.61% -97.97%
FINANCING ACTIVITIES
Cash Dividend Paid $63.03M $58.90M
YoY Change 7.02% 14.05%
Common Stock Issuance & Retirement, Net $67.32M
YoY Change -42.98%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 417.0M -108.6M -$138.7M
YoY Change -1090.57% -21.68% -143.6%
NET CHANGE
Cash From Operating Activities -47.40M -71.53M -$45.63M
Cash From Investing Activities -21.90M -15.05M -$13.73M
Cash From Financing Activities 417.0M -108.6M -$138.7M
Net Change In Cash 347.7M -195.2M -$198.1M
YoY Change 34.41% -1.44% -46.33%
FREE CASH FLOW
Cash From Operating Activities -$47.40M -$71.53M -$45.63M
Capital Expenditures $16.90M $10.49M -$13.73M
Free Cash Flow -$64.30M -$82.02M -$31.90M
YoY Change -122.27% 157.12% 1828.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Interest Expense
InterestExpense
35474000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
24655000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
161388000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
138093000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-191000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
161388000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
138284000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.22
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.22
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
CY2023Q2 us-gaap Profit Loss
ProfitLoss
161388000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
138093000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
3741000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
5759000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
383000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
2000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3358000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5757000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
164746000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
143850000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-191000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
164746000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
144041000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41847000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40102000 usd
CY2023Q2 bah Noncash Lease Expense
NoncashLeaseExpense
13610000 usd
CY2022Q2 bah Noncash Lease Expense
NoncashLeaseExpense
13787000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
17685000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
13696000 usd
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1027000 usd
CY2022Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1161000 usd
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1208000 usd
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1293000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
325363000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
205387000 usd
CY2023Q2 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
31509000 usd
CY2022Q2 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
34802000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10217000 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11241000 usd
CY2023Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-56738000 usd
CY2022Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-61039000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
74389000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4287000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-21877000 usd
CY2022Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-6614000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-71532000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45634000 usd
CY2023Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
10488000 usd
CY2022Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
13734000 usd
CY2023Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
406000 usd
CY2022Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2023Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
4160000 usd
CY2022Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15054000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13734000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6925000 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6081000 usd
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11176000 usd
CY2022Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4596000 usd
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
128390000 usd
CY2022Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
73397000 usd
CY2023Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
63034000 usd
CY2022Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
58899000 usd
CY2023Q2 us-gaap Repayments Of Debt
RepaymentsOfDebt
10313000 usd
CY2022Q2 us-gaap Repayments Of Debt
RepaymentsOfDebt
17095000 usd
CY2023Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
75000000 usd
CY2022Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-108636000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-138714000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-195222000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-198082000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
404862000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
695910000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
209640000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
497828000 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
26091000 usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
8735000 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2868000 usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2952000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
992002000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6925000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11176000 usd
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
112981000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
161388000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3358000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.47
CY2023Q2 us-gaap Dividends Cash
DividendsCash
62482000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17685000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1017071000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1046721000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6081000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4596000 usd
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
57558000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
138093000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5757000 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.43
CY2022Q2 us-gaap Dividends Cash
DividendsCash
58262000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13696000 usd
CY2022Q2 bah Noncontrolling Interest Increase From Contributions
NoncontrollingInterestIncreaseFromContributions
0 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1099124000 usd
CY2023Q2 bah Repurchase Of Stock To Satisfy Tax Withholdings Restricted Stock Amount
RepurchaseOfStockToSatisfyTaxWithholdingsRestrictedStockAmount
12400000 usd
CY2022Q2 bah Repurchase Of Stock To Satisfy Tax Withholdings Restricted Stock Amount
RepurchaseOfStockToSatisfyTaxWithholdingsRestrictedStockAmount
10600000 usd
CY2023Q2 us-gaap Nature Of Operations
NatureOfOperations
Business OverviewBooz Allen Hamilton Holding Corporation, including its wholly owned subsidiaries, or the Company, we, us, and our, was incorporated in Delaware in May 2008. The Company provides management and technology consulting, analytics, engineering, digital solutions, mission operations, and cyber services to U.S. and international governments, major corporations, and not-for-profit organizations. The Company reports operating results and financial data in one reportable segment. The Company is headquartered in McLean, Virginia, with approximately 32,600 employees as of June 30, 2023.
CY2023Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q2 dei Entity Number Of Employees
EntityNumberOfEmployees
32600 employee
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Estimates</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Areas of the financial statements where estimates may have the most significant effect include the provision for claimed indirect costs, valuation and expected lives of tangible and intangible assets, impairment of long-lived assets, accrued liabilities, revenue recognition, including the accrual of indirect costs, bonus and other incentive compensation, stock-based compensation, reserves for uncertain tax positions and valuation allowances on deferred tax assets, provisions for income taxes, postretirement obligations, collectability of receivables, and loss accruals for litigation. Actual results experienced by the Company may differ materially from management's estimates.</span></div>
CY2023Q2 us-gaap Undistributed Earnings
UndistributedEarnings
160146000 usd
CY2022Q2 us-gaap Undistributed Earnings
UndistributedEarnings
137369000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131031979 shares
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2654486000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2249600000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2654486000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2249600000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2654486000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2249600000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
8000000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
7900000000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.75
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.85
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P24M
CY2023Q2 us-gaap Billed Contract Receivables
BilledContractReceivables
745924000 usd
CY2023Q1 us-gaap Billed Contract Receivables
BilledContractReceivables
551666000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1354108000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1223482000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
66000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
318000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2099966000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1774830000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
59733000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
59455000 usd
CY2023Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
2159699000 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
1834285000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13635000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
18995000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
14400000 usd
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
16300000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132371487 shares
CY2023Q2 us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
160149000 usd
CY2022Q2 us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
137372000 usd
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
498654 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
639601 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131530633 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133011088 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.22
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.22
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
CY2023Q2 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
1000000 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
900000 shares
CY2023Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
800000 usd
CY2023Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
800000 usd
CY2022Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
500000 usd
CY2022Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
500000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
2343800000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
2338400000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
729838000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
262258000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
467580000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
733946000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
238531000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
495415000 usd
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
920038000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
262258000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
657780000 usd
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
924146000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
238531000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
685615000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
2812145000 usd
CY2023Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
572355000 usd
CY2023Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
597808000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
818674000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
718832000 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1391029000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1316640000 usd
CY2023Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
27423000 usd
CY2023Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
120023000 usd
CY2023Q2 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent
79115000 usd
CY2023Q1 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent
52480000 usd
CY2023Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
218914000 usd
CY2023Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
203627000 usd
CY2023Q2 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
47054000 usd
CY2023Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
69075000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
372506000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
445205000 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
16480000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
17230000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
2877583000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
116250000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
41250000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2761333000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2770895000 usd
CY2023Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1027000 usd
CY2022Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1161000 usd
CY2023Q2 bah Interest Expense Debt Interest Swap
InterestExpenseDebtInterestSwap
-3568000 usd
CY2022Q2 bah Interest Expense Debt Interest Swap
InterestExpenseDebtInterestSwap
2831000 usd
CY2023Q2 bah Interest Income Expense Other
InterestIncomeExpenseOther
114000 usd
CY2022Q2 bah Interest Income Expense Other
InterestIncomeExpenseOther
94000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
35474000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
24655000 usd
CY2023Q2 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
-14200000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.197
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.231
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 usd
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
23633000 usd
CY2023Q2 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
167821000 usd
CY2023Q1 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
167821000 usd
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
47984000 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
14523000 usd
CY2023Q2 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.06
CY2023Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
54300000 usd
CY2022Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
46200000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
6356000 usd
CY2023Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
2998000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3358000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
3668000 usd
CY2022Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-2089000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5757000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17685000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13696000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17685000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13696000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
102200000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P4Y3M
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
102224000 usd

Files In Submission

Name View Source Status
0001443646-23-000174-index-headers.html Edgar Link pending
0001443646-23-000174-index.html Edgar Link pending
0001443646-23-000174.txt Edgar Link pending
0001443646-23-000174-xbrl.zip Edgar Link pending
bah-20230630.htm Edgar Link pending
bah-20230630.xsd Edgar Link pending
bah-20230630xex311.htm Edgar Link pending
bah-20230630xex312.htm Edgar Link pending
bah-20230630xex321.htm Edgar Link pending
bah-20230630xex322.htm Edgar Link pending
bah-20230630_def.xml Edgar Link unprocessable
bah-20230630_lab.xml Edgar Link unprocessable
bah-20230630_pre.xml Edgar Link unprocessable
bah-20230630_htm.xml Edgar Link completed
exhibit101-bah2023_tenth.htm Edgar Link pending
exhibit101-bah2023_tenth001.jpg Edgar Link pending
exhibit101-bah2023_tenth002.jpg Edgar Link pending
exhibit101-bah2023_tenth003.jpg Edgar Link pending
exhibit101-bah2023_tenth004.jpg Edgar Link pending
exhibit101-bah2023_tenth005.jpg Edgar Link pending
exhibit101-bah2023_tenth006.jpg Edgar Link pending
exhibit101-bah2023_tenth007.jpg Edgar Link pending
exhibit101-bah2023_tenth008.jpg Edgar Link pending
exhibit101-bah2023_tenth009.jpg Edgar Link pending
exhibit101-bah2023_tenth010.jpg Edgar Link pending
exhibit101-bah2023_tenth011.jpg Edgar Link pending
exhibit101-bah2023_tenth012.jpg Edgar Link pending
exhibit101-bah2023_tenth013.jpg Edgar Link pending
exhibit101-bah2023_tenth014.jpg Edgar Link pending
exhibit101-bah2023_tenth015.jpg Edgar Link pending
exhibit101-bah2023_tenth016.jpg Edgar Link pending
exhibit101-bah2023_tenth017.jpg Edgar Link pending
exhibit101-bah2023_tenth018.jpg Edgar Link pending
exhibit101-bah2023_tenth019.jpg Edgar Link pending
exhibit101-bah2023_tenth020.jpg Edgar Link pending
exhibit101-bah2023_tenth021.jpg Edgar Link pending
exhibit101-bah2023_tenth022.jpg Edgar Link pending
exhibit101-bah2023_tenth023.jpg Edgar Link pending
exhibit101-bah2023_tenth024.jpg Edgar Link pending
exhibit101-bah2023_tenth025.jpg Edgar Link pending
exhibit101-bah2023_tenth026.jpg Edgar Link pending
exhibit101-bah2023_tenth027.jpg Edgar Link pending
exhibit101-bah2023_tenth028.jpg Edgar Link pending
exhibit101-bah2023_tenth029.jpg Edgar Link pending
exhibit101-bah2023_tenth030.jpg Edgar Link pending
exhibit101-bah2023_tenth031.jpg Edgar Link pending
exhibit101-bah2023_tenth032.jpg Edgar Link pending
exhibit101-bah2023_tenth033.jpg Edgar Link pending
exhibit101-bah2023_tenth034.jpg Edgar Link pending
exhibit101-bah2023_tenth035.jpg Edgar Link pending
exhibit101-bah2023_tenth036.jpg Edgar Link pending
exhibit101-bah2023_tenth037.jpg Edgar Link pending
exhibit101-bah2023_tenth038.jpg Edgar Link pending
exhibit101-bah2023_tenth039.jpg Edgar Link pending
exhibit101-bah2023_tenth040.jpg Edgar Link pending
exhibit101-bah2023_tenth041.jpg Edgar Link pending
exhibit101-bah2023_tenth042.jpg Edgar Link pending
exhibit101-bah2023_tenth043.jpg Edgar Link pending
exhibit101-bah2023_tenth044.jpg Edgar Link pending
exhibit101-bah2023_tenth045.jpg Edgar Link pending
exhibit101-bah2023_tenth046.jpg Edgar Link pending
exhibit101-bah2023_tenth047.jpg Edgar Link pending
exhibit101-bah2023_tenth048.jpg Edgar Link pending
exhibit101-bah2023_tenth049.jpg Edgar Link pending
exhibit101-bah2023_tenth050.jpg Edgar Link pending
exhibit101-bah2023_tenth051.jpg Edgar Link pending
exhibit101-bah2023_tenth052.jpg Edgar Link pending
exhibit101-bah2023_tenth053.jpg Edgar Link pending
exhibit101-bah2023_tenth054.jpg Edgar Link pending
exhibit101-bah2023_tenth055.jpg Edgar Link pending
exhibit101-bah2023_tenth056.jpg Edgar Link pending
exhibit101-bah2023_tenth057.jpg Edgar Link pending
exhibit101-bah2023_tenth058.jpg Edgar Link pending
exhibit101-bah2023_tenth059.jpg Edgar Link pending
exhibit101-bah2023_tenth060.jpg Edgar Link pending
exhibit101-bah2023_tenth061.jpg Edgar Link pending
exhibit101-bah2023_tenth062.jpg Edgar Link pending
exhibit101-bah2023_tenth063.jpg Edgar Link pending
exhibit101-bah2023_tenth064.jpg Edgar Link pending
exhibit101-bah2023_tenth065.jpg Edgar Link pending
exhibit101-bah2023_tenth066.jpg Edgar Link pending
exhibit101-bah2023_tenth067.jpg Edgar Link pending
exhibit101-bah2023_tenth068.jpg Edgar Link pending
exhibit101-bah2023_tenth069.jpg Edgar Link pending
exhibit101-bah2023_tenth070.jpg Edgar Link pending
exhibit101-bah2023_tenth071.jpg Edgar Link pending
exhibit101-bah2023_tenth072.jpg Edgar Link pending
exhibit101-bah2023_tenth073.jpg Edgar Link pending
exhibit101-bah2023_tenth074.jpg Edgar Link pending
exhibit101-bah2023_tenth075.jpg Edgar Link pending
exhibit101-bah2023_tenth076.jpg Edgar Link pending
exhibit101-bah2023_tenth077.jpg Edgar Link pending
exhibit101-bah2023_tenth078.jpg Edgar Link pending
exhibit101-bah2023_tenth079.jpg Edgar Link pending
exhibit101-bah2023_tenth080.jpg Edgar Link pending
exhibit101-bah2023_tenth081.jpg Edgar Link pending
exhibit101-bah2023_tenth082.jpg Edgar Link pending
exhibit101-bah2023_tenth083.jpg Edgar Link pending
exhibit101-bah2023_tenth084.jpg Edgar Link pending
exhibit101-bah2023_tenth085.jpg Edgar Link pending
exhibit101-bah2023_tenth086.jpg Edgar Link pending
exhibit101-bah2023_tenth087.jpg Edgar Link pending
exhibit101-bah2023_tenth088.jpg Edgar Link pending
exhibit101-bah2023_tenth089.jpg Edgar Link pending
exhibit101-bah2023_tenth090.jpg Edgar Link pending
exhibit101-bah2023_tenth091.jpg Edgar Link pending
exhibit101-bah2023_tenth092.jpg Edgar Link pending
exhibit101-bah2023_tenth093.jpg Edgar Link pending
exhibit101-bah2023_tenth094.jpg Edgar Link pending
exhibit101-bah2023_tenth095.jpg Edgar Link pending
exhibit101-bah2023_tenth096.jpg Edgar Link pending
exhibit101-bah2023_tenth097.jpg Edgar Link pending
exhibit101-bah2023_tenth098.jpg Edgar Link pending
exhibit101-bah2023_tenth099.jpg Edgar Link pending
exhibit101-bah2023_tenth100.jpg Edgar Link pending
exhibit101-bah2023_tenth101.jpg Edgar Link pending
exhibit101-bah2023_tenth102.jpg Edgar Link pending
exhibit101-bah2023_tenth103.jpg Edgar Link pending
exhibit101-bah2023_tenth104.jpg Edgar Link pending
exhibit101-bah2023_tenth105.jpg Edgar Link pending
exhibit101-bah2023_tenth106.jpg Edgar Link pending
exhibit101-bah2023_tenth107.jpg Edgar Link pending
exhibit101-bah2023_tenth108.jpg Edgar Link pending
exhibit101-bah2023_tenth109.jpg Edgar Link pending
exhibit101-bah2023_tenth110.jpg Edgar Link pending
exhibit101-bah2023_tenth111.jpg Edgar Link pending
exhibit101-bah2023_tenth112.jpg Edgar Link pending
exhibit101-bah2023_tenth113.jpg Edgar Link pending
exhibit101-bah2023_tenth114.jpg Edgar Link pending
exhibit101-bah2023_tenth115.jpg Edgar Link pending
exhibit101-bah2023_tenth116.jpg Edgar Link pending
exhibit101-bah2023_tenth117.jpg Edgar Link pending
exhibit101-bah2023_tenth118.jpg Edgar Link pending
exhibit101-bah2023_tenth119.jpg Edgar Link pending
exhibit101-bah2023_tenth120.jpg Edgar Link pending
exhibit101-bah2023_tenth121.jpg Edgar Link pending
exhibit101-bah2023_tenth122.jpg Edgar Link pending
exhibit101-bah2023_tenth123.jpg Edgar Link pending
exhibit101-bah2023_tenth124.jpg Edgar Link pending
exhibit101-bah2023_tenth125.jpg Edgar Link pending
exhibit101-bah2023_tenth126.jpg Edgar Link pending
exhibit101-bah2023_tenth127.jpg Edgar Link pending
exhibit101-bah2023_tenth128.jpg Edgar Link pending
exhibit101-bah2023_tenth129.jpg Edgar Link pending
exhibit101-bah2023_tenth130.jpg Edgar Link pending
exhibit101-bah2023_tenth131.jpg Edgar Link pending
exhibit101-bah2023_tenth132.jpg Edgar Link pending
exhibit101-bah2023_tenth133.jpg Edgar Link pending
exhibit101-bah2023_tenth134.jpg Edgar Link pending
exhibit101-bah2023_tenth135.jpg Edgar Link pending
exhibit101-bah2023_tenth136.jpg Edgar Link pending
exhibit101-bah2023_tenth137.jpg Edgar Link pending
exhibit101-bah2023_tenth138.jpg Edgar Link pending
exhibit101-bah2023_tenth139.jpg Edgar Link pending
exhibit101-bah2023_tenth140.jpg Edgar Link pending
exhibit101-bah2023_tenth141.jpg Edgar Link pending
exhibit101-bah2023_tenth142.jpg Edgar Link pending
exhibit101-bah2023_tenth143.jpg Edgar Link pending
exhibit101-bah2023_tenth144.jpg Edgar Link pending
exhibit101-bah2023_tenth145.jpg Edgar Link pending
exhibit101-bah2023_tenth146.jpg Edgar Link pending
exhibit101-bah2023_tenth147.jpg Edgar Link pending
exhibit101-bah2023_tenth148.jpg Edgar Link pending
exhibit101-bah2023_tenth149.jpg Edgar Link pending
exhibit101-bah2023_tenth150.jpg Edgar Link pending
exhibit101-bah2023_tenth151.jpg Edgar Link pending
exhibit101-bah2023_tenth152.jpg Edgar Link pending
exhibit101-bah2023_tenth153.jpg Edgar Link pending
exhibit101-bah2023_tenth154.jpg Edgar Link pending
exhibit101-bah2023_tenth155.jpg Edgar Link pending
exhibit101-bah2023_tenth156.jpg Edgar Link pending
exhibit101-bah2023_tenth157.jpg Edgar Link pending
exhibit101-bah2023_tenth158.jpg Edgar Link pending
exhibit101-bah2023_tenth159.jpg Edgar Link pending
exhibit101-bah2023_tenth160.jpg Edgar Link pending
exhibit101-bah2023_tenth161.jpg Edgar Link pending
exhibit101-bah2023_tenth162.jpg Edgar Link pending
exhibit101-bah2023_tenth163.jpg Edgar Link pending
exhibit101-bah2023_tenth164.jpg Edgar Link pending
exhibit101-bah2023_tenth165.jpg Edgar Link pending
exhibit101-bah2023_tenth166.jpg Edgar Link pending
exhibit101-bah2023_tenth167.jpg Edgar Link pending
exhibit101-bah2023_tenth168.jpg Edgar Link pending
exhibit101-bah2023_tenth169.jpg Edgar Link pending
exhibit101-bah2023_tenth170.jpg Edgar Link pending
exhibit101-bah2023_tenth171.jpg Edgar Link pending
exhibit101-bah2023_tenth172.jpg Edgar Link pending
exhibit101-bah2023_tenth173.jpg Edgar Link pending
exhibit101-bah2023_tenth174.jpg Edgar Link pending
exhibit101-bah2023_tenth175.jpg Edgar Link pending
exhibit101-bah2023_tenth176.jpg Edgar Link pending
exhibit101-bah2023_tenth177.jpg Edgar Link pending
exhibit101-bah2023_tenth178.jpg Edgar Link pending
exhibit101-bah2023_tenth179.jpg Edgar Link pending
exhibit101-bah2023_tenth180.jpg Edgar Link pending
exhibit101-bah2023_tenth181.jpg Edgar Link pending
exhibit101-bah2023_tenth182.jpg Edgar Link pending
exhibit101-bah2023_tenth183.jpg Edgar Link pending
exhibit101-bah2023_tenth184.jpg Edgar Link pending
exhibit101-bah2023_tenth185.jpg Edgar Link pending
exhibit101-bah2023_tenth186.jpg Edgar Link pending
exhibit101-bah2023_tenth187.jpg Edgar Link pending
exhibit101-bah2023_tenth188.jpg Edgar Link pending
exhibit101-bah2023_tenth189.jpg Edgar Link pending
exhibit101-bah2023_tenth190.jpg Edgar Link pending
exhibit101-bah2023_tenth191.jpg Edgar Link pending
exhibit101-bah2023_tenth192.jpg Edgar Link pending
exhibit101-bah2023_tenth193.jpg Edgar Link pending
exhibit101-bah2023_tenth194.jpg Edgar Link pending
exhibit101-bah2023_tenth195.jpg Edgar Link pending
exhibit102-bah2023_guara.htm Edgar Link pending
exhibit102-bah2023_guara001.jpg Edgar Link pending
exhibit102-bah2023_guara002.jpg Edgar Link pending
exhibit102-bah2023_guara003.jpg Edgar Link pending
exhibit102-bah2023_guara004.jpg Edgar Link pending
exhibit102-bah2023_guara005.jpg Edgar Link pending
exhibit102-bah2023_guara006.jpg Edgar Link pending
exhibit102-bah2023_guara007.jpg Edgar Link pending
exhibit102-bah2023_guara008.jpg Edgar Link pending
exhibit102-bah2023_guara009.jpg Edgar Link pending
exhibit102-bah2023_guara010.jpg Edgar Link pending
exhibit102-bah2023_guara011.jpg Edgar Link pending
exhibit102-bah2023_guara012.jpg Edgar Link pending
exhibit102-bah2023_guara013.jpg Edgar Link pending
exhibit102-bah2023_guara014.jpg Edgar Link pending
exhibit102-bah2023_guara015.jpg Edgar Link pending
exhibit102-bah2023_guara016.jpg Edgar Link pending
exhibit102-bah2023_guara017.jpg Edgar Link pending
exhibit103-boozxxsettlem.htm Edgar Link pending
exhibit103-boozxxsettlem001.jpg Edgar Link pending
exhibit103-boozxxsettlem002.jpg Edgar Link pending
exhibit103-boozxxsettlem003.jpg Edgar Link pending
exhibit103-boozxxsettlem004.jpg Edgar Link pending
exhibit103-boozxxsettlem005.jpg Edgar Link pending
exhibit103-boozxxsettlem006.jpg Edgar Link pending
exhibit103-boozxxsettlem007.jpg Edgar Link pending
exhibit103-boozxxsettlem008.jpg Edgar Link pending
exhibit103-boozxxsettlem009.jpg Edgar Link pending
exhibit103-boozxxsettlem010.jpg Edgar Link pending
exhibit103-boozxxsettlem011.jpg Edgar Link pending
exhibit103-boozxxsettlem012.jpg Edgar Link pending
exhibit103-boozxxsettlem013.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
bah-20230630_cal.xml Edgar Link unprocessable